Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 3, Issue 4, 2001, Pages 401-407

  Luo, Y ^a  

^a The University of Southern Mississippi   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT; GINKGOLIDE B;

ALZHEIMER DISEASE; ARTICLE; CELL SURVIVAL; CHEMICAL COMPOSITION; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; HUMAN; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034853406     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3407     Document Type: Article

References (72)

1. Inhibition of serum deprivation- and sataurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents
2. Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats
3. The cholinergic hypothesis of geriatric memory dysfunction
4. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid
5. Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity
6. Platelet-activating factor antagonist BN 52021 decreases accumulation of free poly unsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock
7. Perspectives in platelet-activating factor research
8. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: Insights into Alzheimer's disease
9. The third intracellular domain of the plalelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins
10. Downregulation of oxidative phosphorylation in Alzheimer disease: Loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex
11. Bilobalide and ginkgo biloba extract (EGb 761) inhibit excitotoxic neuronal death through glycine antagonism
12. Mixture of American ginseng extract, ginkgo biloba extract and St. John's wort extract enhances the survival of axotomized retinal ganglion cells
13. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor
14. Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging
15. Oxidative stress, glutamate, and neurodegenerative disorders
16. Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function
17. Ginkgos and people - A thousand years of interactions
18. Effect of the extract of ginkgo biloba on neurogenesis of olfactory neurons in the adult mouse
19. Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides
20. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid b-peptide: Involvement of calcium and oxyradicals
21. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
22. Neuro-protection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
23. Decreased cerebral 5-HT1a receptors during ageing: Reversal by Ginkgo biloba extract (EGb761)
24. Alpha 2-adrenaceptor changes durring cerebral ageing: The effect of Ginkgo biloba extract
25. Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobaide
26. Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia
27. Ginkgo biloba
28. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity
29. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor
30. In vitro effect of Ginkgo biloba extract (EGb 761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus
31. Production and effects of platelet-activating factor in the rat brain
32. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia, North America1 EGb study group
33. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia
34. Effects of Ginkgo Biloba on changes induced by quantitative cerebral microembolization in rats
35. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinase
36. Distinct patelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
37. Apoptosis in neurodegenerative diseases
38. Clinical efficacy of Ginkgo biloba special extract EGb761 in dementia of the alzheimer type
39. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals
40. The efficacy of Ginkgo biloba on cognitive function in Alzheiner disease
41. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide
42. Age-related changes in the effects of a chronic ultramild stress procedure on decision-making, open-field behaviour and serotoninergic neurotransmission: Influence of a long-term treatment with EGb 761 (tanakan)
43. Reactive oxygen species mediate cellular damage in Alzheimer disease
44. A suicide note from Alzheimer disease neurons?
45. How important is oxidative damage? Lessons from Alzheimer's Disease
46. Ginkgo biloba extract (EGb 761) protects Na, K-ATPase activity during cerebral inschemia in mice
47. Beta-amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants
48. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract
49. Current status of antioxidant therapy for Alzheimer's disease
50. Neurodegenerative diseases and model systems
51. The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytptamine: In-vitro and ex-vitro studies
52. Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task
53. Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): Selective effect in hippocampus as compared with cerebral cortex
54. A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress
55. Mitochondria, oxidative stress and aging
56. In situ methods for detection and localization of markers of oxidative stress: Application in neurodegenerative disorders
57. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal
58. What are the facts and artifacts of the pathogenesis and etiology of Alzheimer disease?
59. The neuroprotective properties of the Ginkgo biloba leaf: A reveiw of the possible relationship to platelet-activating factor (PAF)
60. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediaor
61. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse
62. Effect of EGb761 on lipid peroxidation, DNA repair and antioxienzyme activity
63. Apoptosis in the pathogenesis and treatment of disease
64. Mitochondrial DNA in aging and disease
65. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions
66. Apoptotic signal transduction: Emerging pathways
67. The effects of an extract of Ginkgo biloba, EGb761, on cognitive behavior and longevity in the rat
68. Mechanisms of neuronal degeneration in Alzeimer's disease
69. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides
70. Free radicals and lipid peroxidation do not mediate beta-amyloid-induced neuronal cell death
71. Neurodegeneration induced by verapamil and attenuated by EGb761